The ongoing financial crisis in Asia and the strong U.S. dollar conspired to put the brakes on Acuson's second-quarter financial results. The Mountain View, CA, company last month reported slightly higher revenues for the period (end-July), while net
The ongoing financial crisis in Asia and the strong U.S. dollar conspired to put the brakes on Acuson's second-quarter financial results. The Mountain View, CA, company last month reported slightly higher revenues for the period (end-July), while net income declined.
For the quarter, Acuson turned in revenues of $113.3 million, up only marginally compared with sales of $112.7 million in the second quarter of 1997. The company's net income fell to $4.1 million, compared with a profit of $5.7 million in the same period last year.
Acuson's international revenues fell 16% during the period, due to the Asian crisis and the strong dollar, according to chairman and CEO Samuel Maslak. The company's outlook for the rest of the year is positive, however. The U.S. ultrasound market continues to show strength, and Europe is recovering, Maslak said.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.